Astrazeneca (AZN) Cash from Operations (2014 - 2019)

Astrazeneca (AZN) recorded quarterly Cash from Operations of 387000000.0 in Q1 2019, down 564.62% quarter-over-quarter from 58228387.87 in Q1 2015.

Astrazeneca (AZN) Cash from Operations (2014 - 2019) Analysis & Trends

Astrazeneca's Cash from Operations history runs 3 years deep, the most recent figure standing at 387000000.0 for Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Operations (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	1.82 Bn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	5.33 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	2.51 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	3.83 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	3.92 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	2.19 Bn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	2.54 Bn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	2.62 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	1.10 Bn
10	Astrazeneca	72.15 Bn	64.21 Bn	12.61 Bn	-

Download Data